MedTrace Logo

Evaluation of an Individualised Written Education Package for Stroke Patients

NCT00126295 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 130

Last updated 2005-08-19

No results posted yet for this study

Summary

The primary aim of the randomised controlled trial was to evaluate the effectiveness of a tailored written education package ("What you need to know about stroke") on the outcomes of:

* Knowledge about stroke, self-efficacy, anxiety, depression, perceived health status, satisfaction with the content and presentation of the information received, and desire for additional information for patients following stroke and
* Knowledge about stroke, self-efficacy, anxiety, depression, satisfaction with the content and presentation of the information received, and desire for additional information for their carers.

A secondary aim was to evaluate the effect of written information on the outcomes of knowledge about stroke, self-efficacy, anxiety, depression, and perceived health status of patients following stroke and on knowledge about stroke, self-efficacy, anxiety, and depression of their carers.

Conditions

Interventions

DEVICE

'What you need to know about stroke' education package

Sponsors & Collaborators

  • Medical Benefits Fund of Australia

    lead INDUSTRY

Principal Investigators

  • Tammy C Hoffmann · The University of Queensland

  • Kryss McKenna · The University of Queensland

  • Linda Worrall · The University of Queensland

  • Stephen Read · Royal Brisbane Hospital

Study Design

Allocation
RANDOMIZED
Purpose
ECT
Masking
DOUBLE
Model
SINGLE_GROUP

Eligibility

Min Age
0 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-06-30
Completion
2005-05-31

Countries

  • Australia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00126295 on ClinicalTrials.gov